UFP Technologies will report Q1 2025 financial results on May 6, followed by a conference call at 10 AM ET.
Quiver AI Summary
UFP Technologies, Inc. announced that it will release its financial results for the first quarter ending March 31, 2025, on May 6, 2025, before the market opens. Following the announcement, the company will host a conference call at 10:00 AM Eastern Time to discuss the results, which can be accessed via toll-free and international dial-in numbers. A live webcast of the call will also be available on the company's website, along with a replay post-event. UFP Technologies specializes in designing and manufacturing components for medical devices, sterile packaging, and custom-engineered products, serving as a vital partner in the medical device supply chain for leading manufacturers.
Potential Positives
- UFP Technologies is scheduled to report its financial results on May 6, 2025, highlighting the company's commitment to transparency and open communication with investors.
- The upcoming conference call provides an opportunity for direct engagement between management and investors, which can enhance shareholder relations.
- The company's role as a valued partner in the medical device supply chain underscores its significance in a growing and essential industry.
Potential Negatives
- Announcement of upcoming financial results may indicate uncertainty or concerns about current performance if not delivered on a consistent schedule.
- The delay in reporting quarterly results could raise concerns among investors regarding financial transparency and operational stability.
FAQ
When will UFP Technologies report its financial results?
UFP Technologies plans to report financial results for the first quarter on May 6, 2025.
What time is the conference call for UFP Technologies' results?
The conference call to discuss UFP Technologies' results will be held at 10:00 AM Eastern Time on May 6, 2025.
How can I join the UFP Technologies conference call?
Participants can join the call using the toll-free number 1-888-243-4451 or the international number 1-412-542-4135.
Will there be a webcast of the conference call?
Yes, a live webcast of the conference call will be available at www.ufpt.com.
Where can I find UFP Technologies' financial results after the call?
A replay of the webcast and financial results will be accessible on the Company’s Investor Relations website.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$UFPT Insider Trading Activity
$UFPT insiders have traded $UFPT stock on the open market 38 times in the past 6 months. Of those trades, 1 have been purchases and 37 have been sales.
Here’s a breakdown of recent trading of $UFPT stock by insiders over the last 6 months:
- R JEFFREY BAILLY (CEO) has made 0 purchases and 22 sales selling 40,437 shares for an estimated $14,057,292.
- DANIEL C CROTEAU has made 0 purchases and 8 sales selling 6,846 shares for an estimated $1,563,723.
- CYNTHIA L FELDMANN has made 0 purchases and 3 sales selling 3,403 shares for an estimated $863,813.
- SYMERIA HUDSON has made 0 purchases and 3 sales selling 2,293 shares for an estimated $781,518.
- RONALD J LATAILLE (Chief Financial Officer) purchased 400 shares for an estimated $91,635
- JASON HOLT (Vice President) sold 146 shares for an estimated $50,032
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$UFPT Hedge Fund Activity
We have seen 147 institutional investors add shares of $UFPT stock to their portfolio, and 127 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WASATCH ADVISORS LP added 156,142 shares (+37.1%) to their portfolio in Q4 2024, for an estimated $38,178,280
- BOSTON TRUST WALDEN CORP added 106,197 shares (+98.4%) to their portfolio in Q1 2025, for an estimated $21,420,996
- NEUBERGER BERMAN GROUP LLC removed 102,076 shares (-18.7%) from their portfolio in Q4 2024, for an estimated $24,958,602
- UBS GROUP AG added 72,051 shares (+1494.2%) to their portfolio in Q4 2024, for an estimated $17,617,190
- PRICE T ROWE ASSOCIATES INC /MD/ added 63,899 shares (+55.8%) to their portfolio in Q4 2024, for an estimated $15,623,944
- ROYAL BANK OF CANADA added 57,787 shares (+508.8%) to their portfolio in Q4 2024, for an estimated $14,129,499
- ENVESTNET ASSET MANAGEMENT INC added 54,382 shares (+261.3%) to their portfolio in Q1 2025, for an estimated $10,969,393
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
NEWBURYPORT, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ: UFPT), an innovative designer and custom manufacturer of components for medical devices, sterile packaging, and other highly engineered products, today announced the Company plans to report financial results for the first quarter ended March 31, 2025 on May 6, 2025 prior to market open. The Company will hold a conference call to discuss results the same day at 10:00 AM Eastern time.
Conference Call Information:
Date:
Tuesday, May 6, 2025
Time:
10:00 AM Eastern Time
Participants may join the call using the following dial-in numbers:
- Toll-Free: 1-888-243-4451
- International: 1-412-542-4135
A live webcast of the conference call and accompanying materials will be available at
www.ufpt.com
.
A replay of the webcast will be accessible following the event on the Company’s Investor Relations website at
https://ufpt.com/investors/
.
About UFP Technologies, Inc.
UFP Technologies is an innovative designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products. UFP is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The Company’s single-use and single-patient devices and components are used in a wide range of medical devices and packaging for minimally invasive surgery, infection prevention, wound care, wearables, orthopedic soft goods, and orthopedic implants.
Company Contact:
Ron Lataille, Sr. Vice President, Treasurer, and Chief Financial Officer
(978) 234-0926
[email protected]
Investor Contact:
Jeff Elliott or Phillip Kupper
Three Part Advisors
(214) 966-9014 or (817) 778-8339
www.threepa.com
